Recursion Pharmaceuticals, Inc. (RXRX) Expected Move
Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.
Snapshot as of Apr 24, 2026.
- Spot Price
- $3.51
- Expected Move
- 23.8%
- Implied High
- $4.34
- Implied Low
- $2.68
- Front DTE
- 28 days
As of Apr 24, 2026, Recursion Pharmaceuticals, Inc. (RXRX) has an expected move of 23.79% — a one-standard-deviation implied price range of roughly $2.68 to $4.34 from the current $3.51. Expected move is derived from at-the-money straddle pricing and represents the market's pricing of a ±1σ move. Roughly 68% of outcomes should fall within this range under lognormal assumptions, though empirical markets have fatter tails.
Per-expiration expected move for RXRX derived from ATM implied volatility at each listed expiration. Implied high/low bounds are computed as $3.51 × (1 ± expected move %). One standard-deviation range under lognormal assumptions — roughly 68% of outcomes fall inside.
| Expiration | DTE | ATM IV | Expected Move | Implied High | Implied Low |
|---|---|---|---|---|---|
| May 1, 2026 | 7 | 80.5% | 11.1% | $3.90 | $3.12 |
| May 8, 2026 | 14 | 88.2% | 17.3% | $4.12 | $2.90 |
| May 15, 2026 | 21 | 76.8% | 18.4% | $4.16 | $2.86 |
| May 22, 2026 | 28 | 83.6% | 23.2% | $4.32 | $2.70 |
| May 29, 2026 | 35 | 81.7% | 25.3% | $4.40 | $2.62 |
| Jun 5, 2026 | 42 | 79.6% | 27.0% | $4.46 | $2.56 |
| Jun 18, 2026 | 55 | 82.8% | 32.1% | $4.64 | $2.38 |
| Jul 17, 2026 | 84 | 93.8% | 45.0% | $5.09 | $1.93 |
| Aug 21, 2026 | 119 | 90.4% | 51.6% | $5.32 | $1.70 |
| Sep 18, 2026 | 147 | 85.2% | 54.1% | $5.41 | $1.61 |
| Nov 20, 2026 | 210 | 85.9% | 65.2% | $5.80 | $1.22 |
| Dec 18, 2026 | 238 | 83.1% | 67.1% | $5.87 | $1.15 |
| Jan 15, 2027 | 266 | 85.8% | 73.2% | $6.08 | $0.94 |
| Jan 21, 2028 | 637 | 100.5% | 132.8% | $8.17 | $-1.15 |